Here’s Trump’s negotiating playbook in a nutshell.
Start from an extreme “unreasonable” position to force people to pay attention and come to the table…
And then scale it back to a solution both sides can agree on.
It’s happened time and time again…
And yet, every time he whips out the same playbook, people keep reacting the same way.
They throw their hands in the air and panic, proclaim the world is over and blah blah blah.
So it’s no wonder Trump keeps exploiting it – because it still keeps working.
It’s the same with us traders and our edges.
As long as it keeps working, we’re going to keep exploiting it.
And when you boil it down to its core…
Trump’s playbook is nothing more than "profiting" from overreactions.
If that sounds familiar…
It’s because that’s the exact same strategy the corporate insiders use….
Especially during earnings season – which we are in now.
They wait for investors to overreact to earnings announcements – which usually sends the stock downward.
And then they swoop in and load up on more shares at bargain prices.
One of the biggest examples is a tiny biotech called Alumis Inc. (ALMS).
It got absolutely wrecked during earnings last November.
Several key insiders used the chance to buy in big…
Just weeks before the company announced successful Phase 3 clinical trial results for its plaque psoriasis drug.
Luckily I had already spotted this insider activity…
And issued a buy alert to my insider members – allowing them to profit from the stock’s huge pop.
